iTeos Therapeutics, Inc.
ITOSDelisted Aug 29, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001808865
iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.
13F holders, Q2 2025
Institutional positions in iTeos Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ITOS is no longer listed, so this page shows Q2 2025. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 137
- +5 vs. Q1 2025
- Shares held
- 37.8M
- +848.1K (+2.3%) vs. Q1 2025
- Total value
- $377.0M
- +$156.3M (+70.8%) vs. Q1 2025
- New holders
- 40
- 57 more added
- Sold out
- 35
- 30 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ITOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $2.35K |
| Q2 2025 | 137 | $377.0M |
| Q1 2025 | 132 | $220.7M |
| Q4 2024 | 137 | $262.2M |
| Q3 2024 | 151 | $373.3M |
| Q2 2024 | 139 | $536.8M |
| Q1 2024 | 136 | $471.2M |
| Q4 2023 | 138 | $383.4M |
| Q3 2023 | 144 | $388.6M |
| Q2 2023 | 146 | $460.4M |
| Q1 2023 | 153 | $488.9M |
| Q4 2022 | 146 | $707.3M |
| Q3 2022 | 143 | $698.2M |
| Q2 2022 | 153 | $768.1M |
| Q1 2022 | 159 | $1.17B |
| Q4 2021 | 118 | $1.55B |
| Q3 2021 | 77 | $841.3M |
| Q2 2021 | 83 | $755.8M |
| Q1 2021 | 81 | $1.03B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding iTeos Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wellington Management Group LLP | 154,963 | $1.54M | 0.00% | +14,844+10.6% | Added |
| Goldman Sachs Group Inc | 155,351 | $1.55M | 0.00% | −432,069−73.6% | Reduced |
| Peapod Lane Capital LLC | 169,287 | $1.69M | 1.69% | +33,632+24.8% | Added |
| Royal Bank of Canada | 185,760 | $1.85M | 0.00% | +184,051+10,769.5% | Added |
| Acadian Asset Management LLC | 186,692 | $1.86M | 0.00% | −350,095−65.2% | Reduced |
| Susquehanna Portfolio Strategies, LLC | 204,708 | $2.04M | 0.04% | +204,708 | New |
| Diadema Partners LP | 206,200 | $2.06M | 1.28% | +206,200 | New |
| Ameriprise Financial Inc | 207,787 | $2.07M | 0.00% | +9,885+5.0% | Added |
| Shay Capital LLC | 210,516 | $2.10M | 0.48% | +210,516 | New |
| Alpine Global Management, LLC | 225,000 | $2.24M | 0.51% | +225,000 | New |
| AQR Capital Management LLC | 237,805 | $2.37M | 0.00% | +11,595+5.1% | Added |
| Charles Schwab Investment Management Inc | 246,086 | $2.45M | 0.00% | +12,525+5.4% | Added |
| Northern Trust Corp | 258,369 | $2.58M | 0.00% | +8,244+3.3% | Added |
| Silver Point Capital L.P. | 290,000 | $2.89M | 0.20% | +290,000 | New |
| Rangeley Capital, LLC | 302,080 | $3.01M | 3.79% | +302,080 | New |
| Bank of America Corp | 308,660 | $3.08M | 0.00% | +128,556+71.4% | Added |
| Stonepine Capital Management, LLC | 310,033 | $3.09M | 3.04% | +200,033+181.8% | Added |
| Morgan Stanley | 429,340 | $4.28M | 0.00% | +178,209+71.0% | Added |
| Millennium Management LLC | 477,189 | $4.76M | 0.00% | +128,830+37.0% | Added |
| Almitas Capital LLC | 487,204 | $4.86M | 1.23% | +212,084+77.1% | Added |
| Alyeska Investment Group, L.P. | 500,000 | $4.99M | 0.02% | +500,000 | New |
| LMR Partners LLP | 550,000 | $5.48M | 0.09% | +550,000 | New |
| Newtyn Management, LLC | 567,416 | $5.66M | 0.86% | +567,416 | New |
| DLD Asset Management, LP | 576,655 | $5.75M | 0.68% | +576,655 | New |
| State Street Corp | 594,555 | $5.93M | 0.00% | +12,558+2.2% | Added |
| Nantahala Capital Management, LLC | 596,666 | $5.95M | 0.42% | +596,666 | New |
| JPMorgan Chase & Co | 601,363 | $6.00M | 0.00% | −1,381,300−69.7% | Reduced |
| Renaissance Technologies LLC | 602,100 | $6.00M | 0.01% | −43,500−6.7% | Reduced |
| Marshall Wace, LLP | 611,649 | $6.10M | 0.01% | +492,091+411.6% | Added |
| OrbiMed Advisors LLC | 700,000 | $6.98M | 0.18% | +700,000 | New |
| Geode Capital Management, LLC | 703,467 | $7.02M | 0.00% | +53,414+8.2% | Added |
| Boxer Capital Management, LLC | 825,000 | $8.23M | 4.14% | +825,000 | New |
| Dimensional Fund Advisors LP | 832,761 | $8.30M | 0.00% | −348,493−29.5% | Reduced |
| Vanguard Group Inc | 1,664,161 | $16.6M | 0.00% | −62,297−3.6% | Reduced |
| Tang Capital Management LLC | 3,826,692 | $38.2M | 1.93% | +1,137,492+42.3% | Added |
| BlackRock, Inc. | 4,574,537 | $45.6M | 0.00% | +65,290+1.4% | Added |
| EcoR1 Capital, LLC | 10,688,978 | $106.6M | 6.32% | +10,688,978 | New |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −3,649,057−100.0% | Sold out |
| BVF Inc | 0 | $0 | 0.00% | −3,075,000−100.0% | Sold out |
| MPM Asset Management LLC | 0 | $0 | 0.00% | −2,738,785−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −1,750,000−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −1,745,943−100.0% | Sold out |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −900,000−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −557,936−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −188,500−100.0% | Sold out |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −154,717−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −112,092−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −107,764−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −102,188−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −78,585−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −64,368−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −58,022−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −57,877−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −56,887−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −37,300−100.0% | Sold out |
| K2 Principal Fund, L.P. | 0 | $0 | 0.00% | −29,178−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −18,279−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −17,308−100.0% | Sold out |
| Readystate Asset Management LP | 0 | $0 | 0.00% | −17,040−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −13,498−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −13,036−100.0% | Sold out |
| Clear Harbor Asset Management, LLC | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −12,327−100.0% | Sold out |
| Forefront Analytics, LLC | 0 | $0 | 0.00% | −11,061−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −10,947−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −2,154−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −985−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −127−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −81−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −54−100.0% | Sold out |